Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma
Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page
- Check2 days agoChange DetectedThe screenshots show updates to the record history (additional version entries and status notes) rather than substantive changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check30 days agoChange DetectedAdds a government-status notice and a new software version (v3.2.0); removes the old version tag (v3.1.0).SummaryDifference10%

- Check37 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page version updates from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed; overall, this is a minor update with no impact on core content.SummaryDifference0.6%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, pricing, or availability.SummaryDifference0.6%

- Check66 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference46%

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma
Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.